JP2016534984A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534984A5 JP2016534984A5 JP2016519325A JP2016519325A JP2016534984A5 JP 2016534984 A5 JP2016534984 A5 JP 2016534984A5 JP 2016519325 A JP2016519325 A JP 2016519325A JP 2016519325 A JP2016519325 A JP 2016519325A JP 2016534984 A5 JP2016534984 A5 JP 2016534984A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- heteroaryl
- aryl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052757 nitrogen Inorganic materials 0.000 claims 48
- 229910052760 oxygen Inorganic materials 0.000 claims 46
- 125000001072 heteroaryl group Chemical group 0.000 claims 43
- 125000003118 aryl group Chemical group 0.000 claims 41
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 33
- 125000000753 cycloalkyl group Chemical group 0.000 claims 33
- 229910052717 sulfur Inorganic materials 0.000 claims 30
- 150000001875 compounds Chemical class 0.000 claims 24
- 150000003839 salts Chemical class 0.000 claims 19
- 150000001409 amidines Chemical class 0.000 claims 12
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims 12
- -1 or N Inorganic materials 0.000 claims 10
- 125000001544 thienyl group Chemical group 0.000 claims 4
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims 3
- 125000004404 heteroalkyl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000002785 azepinyl group Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 125000003585 oxepinyl group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000003944 tolyl group Chemical group 0.000 claims 2
- 125000005023 xylyl group Chemical group 0.000 claims 2
- FRVQGCBWBSJTQC-UHFFFAOYSA-N CCc1nc(sc1C(=O)NCCOCCOCCN)N1CCC(CC1)C1CCN(CC1)C(=O)c1ccc(cc1)-c1nc2ccccc2[nH]1 Chemical compound CCc1nc(sc1C(=O)NCCOCCOCCN)N1CCC(CC1)C1CCN(CC1)C(=O)c1ccc(cc1)-c1nc2ccccc2[nH]1 FRVQGCBWBSJTQC-UHFFFAOYSA-N 0.000 claims 1
- ZFOFFCQSWVUJAX-UHFFFAOYSA-N NCCOCCOCCNC(=O)c1ccc2nc([nH]c2c1)-c1ccccc1 Chemical compound NCCOCCOCCNC(=O)c1ccc2nc([nH]c2c1)-c1ccccc1 ZFOFFCQSWVUJAX-UHFFFAOYSA-N 0.000 claims 1
- 241000534944 Thia Species 0.000 claims 1
- 238000001042 affinity chromatography Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- GGNIKGLUPSHSBV-UHFFFAOYSA-N thiazole-5-carboxamide Chemical compound NC(=O)C1=CN=CS1 GGNIKGLUPSHSBV-UHFFFAOYSA-N 0.000 claims 1
- 0 *NC(c1cccc(NC(OC(CC2)CCN2C(c2ccc(*=*(*3)c4ccccc4)c3c2)=O)=O)c1)=O Chemical compound *NC(c1cccc(NC(OC(CC2)CCN2C(c2ccc(*=*(*3)c4ccccc4)c3c2)=O)=O)c1)=O 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361885146P | 2013-10-01 | 2013-10-01 | |
| US61/885,146 | 2013-10-01 | ||
| US201462025994P | 2014-07-17 | 2014-07-17 | |
| US62/025,994 | 2014-07-17 | ||
| PCT/IB2014/064998 WO2015049651A1 (en) | 2013-10-01 | 2014-10-01 | Compounds for affinity chromatography and for extending the half-life of a therapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016534984A JP2016534984A (ja) | 2016-11-10 |
| JP2016534984A5 true JP2016534984A5 (enExample) | 2017-11-16 |
Family
ID=51743521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016519325A Pending JP2016534984A (ja) | 2013-10-01 | 2014-10-01 | アフィニティークロマトグラフィーのためおよび治療薬の半減期の延長のための化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9809558B2 (enExample) |
| EP (1) | EP3052483B1 (enExample) |
| JP (1) | JP2016534984A (enExample) |
| KR (1) | KR20160060660A (enExample) |
| CN (1) | CN105593222B (enExample) |
| AU (1) | AU2014330781B2 (enExample) |
| BR (1) | BR112016007371A2 (enExample) |
| CA (1) | CA2925862A1 (enExample) |
| ES (1) | ES2721098T3 (enExample) |
| RU (1) | RU2016117052A (enExample) |
| SG (1) | SG11201601870VA (enExample) |
| WO (1) | WO2015049651A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170066839A1 (en) | 2015-09-08 | 2017-03-09 | Merck Patent Gmbh | Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies |
| US10697982B2 (en) | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies |
| US10697983B2 (en) | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies |
| US20200047084A1 (en) * | 2017-03-30 | 2020-02-13 | Hitachi Chemical Company, Ltd. | Separation material |
| JP7688395B2 (ja) * | 2018-11-26 | 2025-06-04 | ノース カロライナ ステイト ユニヴァーシティ | 宿主細胞タンパク質の捕捉のためのペプチドリガンド |
| MX2021007444A (es) | 2018-12-21 | 2021-08-05 | Jiangsu Hengrui Medicine Co | Proteina biespecifica. |
| HUE069128T2 (hu) | 2019-12-06 | 2025-02-28 | Vertex Pharma | Szubsztituált tetrahidrofurán vegyületek mint nátriumcsatornák modulátorai |
| AU2022284886A1 (en) | 2021-06-04 | 2023-11-30 | Vertex Pharmaceuticals Incorporated | N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels |
| WO2022266236A1 (en) | 2021-06-18 | 2022-12-22 | Aligos Therapeutics, Inc. | Methods and compositions for targeting pd-l1 |
| US12428427B2 (en) | 2021-12-16 | 2025-09-30 | Aligos Therapeutics, Inc. | Methods and compositions for targeting PD-L1 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH187973A4 (de) * | 1973-02-09 | 1977-03-31 | Hoechst Ag | Verfahren zum optischen Aufhellen von Textilmaterialien |
| US4722896A (en) | 1981-01-26 | 1988-02-02 | The Beth Israel Hospital Association | Method for affinity purification of hybridoma antibodies |
| US5849874A (en) | 1991-07-12 | 1998-12-15 | Gist-Brocades, N.V. | Process for the purification of serum albumin |
| JP2825755B2 (ja) * | 1993-04-07 | 1998-11-18 | 大塚製薬株式会社 | ピペリジン誘導体を有効成分とする末梢血管拡張剤および新規ピペリジン誘導体 |
| US5935927A (en) * | 1994-02-03 | 1999-08-10 | The Picower Institute For Medical Research | Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts |
| GB9914825D0 (en) * | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| NZ514403A (en) | 1999-12-27 | 2002-10-25 | Japan Tobacco Inc | Fused-ring compounds and use thereof as drugs |
| DE10139416A1 (de) * | 2001-08-17 | 2003-03-06 | Aventis Pharma Gmbh | Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| GB2403222A (en) | 2002-04-01 | 2004-12-29 | Utah Ventures Ii L P | Tissue-specific endothelial membrane proteins |
| DE60326735D1 (de) | 2002-08-02 | 2009-04-30 | Genesoft Pharmaceuticals Inc | Biaryl-verbindungen mit antiinfektiver wirkung |
| US7777051B2 (en) | 2003-05-13 | 2010-08-17 | Icagen, Inc. | Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| EP2298770A1 (en) | 2005-11-03 | 2011-03-23 | ChemBridge Corporation | Heterocyclic compounds as TrkA modulators |
| LT2459220T (lt) | 2009-07-31 | 2020-12-28 | Ascendis Pharma A/S | Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu |
| JP5744886B2 (ja) * | 2009-10-19 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | シクロペンタンカルボキサミド誘導体、このような化合物を含む薬物及びそれらの使用 |
| JP2013538798A (ja) * | 2010-08-03 | 2013-10-17 | グラフィニティ ファーマシューティカルズ ゲーエムベーハー | アフィニティクロマトグラフィーによる抗体およびＦｃ融合タンパク質精製のためのリガンド |
| WO2012020080A2 (en) | 2010-08-12 | 2012-02-16 | Graffinity Pharmaceuticals Gmbh | LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY II |
| US9480751B2 (en) | 2011-04-11 | 2016-11-01 | Yeda Research And Development Co. Ltd. | Albumin binding probes and drug conjugates thereof |
| UA115576C2 (uk) | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
| EP2752426A1 (en) | 2013-01-03 | 2014-07-09 | Covagen AG | Human serum albumin binding compounds and fusion proteins thereof |
-
2014
- 2014-10-01 CA CA2925862A patent/CA2925862A1/en not_active Abandoned
- 2014-10-01 AU AU2014330781A patent/AU2014330781B2/en not_active Ceased
- 2014-10-01 BR BR112016007371A patent/BR112016007371A2/pt not_active Application Discontinuation
- 2014-10-01 WO PCT/IB2014/064998 patent/WO2015049651A1/en not_active Ceased
- 2014-10-01 US US15/026,725 patent/US9809558B2/en not_active Expired - Fee Related
- 2014-10-01 JP JP2016519325A patent/JP2016534984A/ja active Pending
- 2014-10-01 EP EP14786355.9A patent/EP3052483B1/en active Active
- 2014-10-01 SG SG11201601870VA patent/SG11201601870VA/en unknown
- 2014-10-01 CN CN201480054551.4A patent/CN105593222B/zh not_active Expired - Fee Related
- 2014-10-01 KR KR1020167008267A patent/KR20160060660A/ko not_active Withdrawn
- 2014-10-01 ES ES14786355T patent/ES2721098T3/es active Active
- 2014-10-01 RU RU2016117052A patent/RU2016117052A/ru not_active Application Discontinuation
-
2017
- 2017-09-07 US US15/698,020 patent/US9938243B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016534984A5 (enExample) | ||
| RU2016117052A (ru) | Соединения для аффинной хроматографии и для продления времени полужизни терапевтического средства | |
| JP2006524222A5 (enExample) | ||
| JP2013517283A5 (enExample) | ||
| PE20090297A1 (es) | Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis | |
| JP2014511869A5 (enExample) | ||
| JP2008516986A5 (enExample) | ||
| AR089134A1 (es) | Arilos y heteroarilos biciclicos inhibidores de los canales de sodio | |
| JP2016053042A5 (enExample) | ||
| JP2010506825A5 (enExample) | ||
| JP2011524422A5 (enExample) | ||
| JP2016540742A5 (enExample) | ||
| JP2010540462A5 (enExample) | ||
| JP2007530459A5 (enExample) | ||
| JP2007519695A5 (enExample) | ||
| CN107207489A (zh) | 作为nadph氧化酶抑制剂的酰氨基噻二唑衍生物 | |
| JP2014521653A5 (enExample) | ||
| PE20141375A1 (es) | Activadores de glucoquinasa | |
| PE20081530A1 (es) | Nuevos compuestos 617 | |
| JP2016503009A5 (enExample) | ||
| JP2016505614A5 (enExample) | ||
| JP2016540811A5 (enExample) | ||
| RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
| JP2017518344A5 (enExample) | ||
| RU2018109925A (ru) | Галогензамещенное гетероциклическое соединение |